Exploring the link between self-rated poor oral health and cardiovascular risk: a cross-sectional study using SCORE2.
Peter Nymberg, Veronica Milos-Nymberg, Anton Grundberg...
https://pubmed.ncbi.nlm.nih.gov/39994610/Actively Recruiting
Led by Region Skane · Updated on 2026-10-29
18000
Participants Needed
1
Research Sites
521 weeks
Total Duration
Researchers are studying the impact of Targeted Health Dialogues in primary care to improve cardiovascular health and prevent serious diseases like cancer among middle-aged adults in the Ske5ne region of Sweden. This observational program enrolls all 40-year-olds, and soon 50- and 60-year-olds, collecting clinical, laboratory, and detailed questionnaire data on health behaviors, symptoms, family history, and lifestyle factors. The study links these data with national and regional health records and sociodemographic information to better understand disease risks and prevention effects. Participants complete questionnaires and undergo measurements including blood pressure, BMI, waist-to-hip ratio, blood glucose, and cholesterol tests. Health results are summarized in a health curve which is reviewed during a targeted dialogue with trained healthcare personnel. A subgroup also provides blood samples for molecular biomarker analysis. The study evaluates how health dialogues influence disease incidence and health behaviors and explores whether personal characteristics modify these effects. Throughout the study, data on hospital admissions, diagnoses, prescriptions, causes of death, and neighborhood and family details are collected and linked to participant information. Researchers will assess outcomes such as cardiovascular disease incidence, cancer, molecular markers, health behaviors, and healthcare use. The study duration extends to 2040, with primary outcome measurements planned by 2035, aiming to refine personalized prevention strategies in primary care.
CONDITIONS
Targeted Health Dialogues in Primary Care
K
Kristina Sundquist, PhD, MD
H
Hanna Glock, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Region Skane
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Ongoing throughout the program
Participants complete questionnaires, undergo physical measurements, and provide blood samples. Health results are discussed with trained healthcare personnel during a targeted health dialogue.
1 visit and possible additional visits for blood sample collection
Duration - Up to 20 years
Researchers link participant data to health records and registries to track disease outcomes and assess the prevention program's effectiveness over time.
No regular visits; data collected through records
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Peter Nymberg, Veronica Milos-Nymberg, Anton Grundberg...
https://pubmed.ncbi.nlm.nih.gov/39994610/Emelie Stenman, Beata Borgström Bolmsjö, Anton Grundberg...
https://pubmed.ncbi.nlm.nih.gov/39091122/Region Skane
Lead Sponsor